287 related articles for article (PubMed ID: 23623334)
1. Wogonin ameliorates hyperglycemia and dyslipidemia via PPARα activation in db/db mice.
Bak EJ; Kim J; Choi YH; Kim JH; Lee DE; Woo GH; Cha JH; Yoo YJ
Clin Nutr; 2014 Feb; 33(1):156-63. PubMed ID: 23623334
[TBL] [Abstract][Full Text] [Related]
2. Wogonin suppresses osteopontin expression in adipocytes by activating PPARα.
Zhang YM; Li MX; Tang Z; Wang CH
Acta Pharmacol Sin; 2015 Aug; 36(8):987-97. PubMed ID: 26073326
[TBL] [Abstract][Full Text] [Related]
3. LT175 is a novel PPARα/γ ligand with potent insulin-sensitizing effects and reduced adipogenic properties.
Gilardi F; Giudici M; Mitro N; Maschi O; Guerrini U; Rando G; Maggi A; Cermenati G; Laghezza A; Loiodice F; Pochetti G; Lavecchia A; Caruso D; De Fabiani E; Bamberg K; Crestani M
J Biol Chem; 2014 Mar; 289(10):6908-6920. PubMed ID: 24451380
[TBL] [Abstract][Full Text] [Related]
4. P633H, a novel dual agonist at peroxisome proliferator-activated receptors alpha and gamma, with different anti-diabetic effects in db/db and KK-Ay mice.
Chen W; Zhou XB; Liu HY; Xu C; Wang LL; Li S
Br J Pharmacol; 2009 Jul; 157(5):724-35. PubMed ID: 19422369
[TBL] [Abstract][Full Text] [Related]
5. Cilostazol ameliorates metabolic abnormalities with suppression of proinflammatory markers in a db/db mouse model of type 2 diabetes via activation of peroxisome proliferator-activated receptor gamma transcription.
Park SY; Shin HK; Lee JH; Kim CD; Lee WS; Rhim BY; Hong KW
J Pharmacol Exp Ther; 2009 May; 329(2):571-9. PubMed ID: 19221061
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of cobalt and mercury on lipid metabolism in the white adipose tissue of high-fat diet-induced obesity mice.
Kawakami T; Hanao N; Nishiyama K; Kadota Y; Inoue M; Sato M; Suzuki S
Toxicol Appl Pharmacol; 2012 Jan; 258(1):32-42. PubMed ID: 22019852
[TBL] [Abstract][Full Text] [Related]
7. Salvianolic Acid B Ameliorates Hyperglycemia and Dyslipidemia in db/db Mice through the AMPK Pathway.
Huang MQ; Zhou CJ; Zhang YP; Zhang XQ; Xu W; Lin J; Wang PJ
Cell Physiol Biochem; 2016; 40(5):933-943. PubMed ID: 27941340
[TBL] [Abstract][Full Text] [Related]
8. Constituents from Terminalia species increase PPARα and PPARγ levels and stimulate glucose uptake without enhancing adipocyte differentiation.
Yang MH; Vasquez Y; Ali Z; Khan IA; Khan SI
J Ethnopharmacol; 2013 Sep; 149(2):490-8. PubMed ID: 23850833
[TBL] [Abstract][Full Text] [Related]
9. Wogonin mitigates nonalcoholic fatty liver disease via enhancing PPARα/AdipoR2, in vivo and in vitro.
Chen J; Liu J; Wang Y; Hu X; Zhou F; Hu Y; Yuan Y; Xu Y
Biomed Pharmacother; 2017 Jul; 91():621-631. PubMed ID: 28486193
[TBL] [Abstract][Full Text] [Related]
10. Osthole, a potential antidiabetic agent, alleviates hyperglycemia in db/db mice.
Liang HJ; Suk FM; Wang CK; Hung LF; Liu DZ; Chen NQ; Chen YC; Chang CC; Liang YC
Chem Biol Interact; 2009 Oct; 181(3):309-15. PubMed ID: 19682441
[TBL] [Abstract][Full Text] [Related]
11. Activation of AMPK-Sirt1 pathway by telmisartan in white adipose tissue: A possible link to anti-metabolic effects.
Shiota A; Shimabukuro M; Fukuda D; Soeki T; Sato H; Uematsu E; Hirata Y; Kurobe H; Sakaue H; Nakaya Y; Masuzaki H; Sata M
Eur J Pharmacol; 2012 Oct; 692(1-3):84-90. PubMed ID: 22819702
[TBL] [Abstract][Full Text] [Related]
12. C333H, a novel PPARalpha/gamma dual agonist, has beneficial effects on insulin resistance and lipid metabolism.
Xu C; Wang LL; Liu HY; Zhou XB; Cao YL; Li S
Acta Pharmacol Sin; 2006 Feb; 27(2):223-8. PubMed ID: 16412273
[TBL] [Abstract][Full Text] [Related]
13. Lipolytic and antiadipogenic effects of (3,3-dimethylallyl) halfordinol on 3T3-L1 adipocytes and high fat and fructose diet induced obese C57/BL6J mice.
Saravanan M; Pandikumar P; Saravanan S; Toppo E; Pazhanivel N; Ignacimuthu S
Eur J Pharmacol; 2014 Oct; 740():714-21. PubMed ID: 24952133
[TBL] [Abstract][Full Text] [Related]
14. A peroxisome proliferator-activated receptor alpha/gamma dual agonist with a unique in vitro profile and potent glucose and lipid effects in rodent models of type 2 diabetes and dyslipidemia.
Reifel-Miller A; Otto K; Hawkins E; Barr R; Bensch WR; Bull C; Dana S; Klausing K; Martin JA; Rafaeloff-Phail R; Rafizadeh-Montrose C; Rhodes G; Robey R; Rojo I; Rungta D; Snyder D; Wilbur K; Zhang T; Zink R; Warshawsky A; Brozinick JT
Mol Endocrinol; 2005 Jun; 19(6):1593-605. PubMed ID: 15831517
[TBL] [Abstract][Full Text] [Related]
15. Anti-diabetic effect of amorphastilbol through PPARα/γ dual activation in db/db mice.
Lee W; Ham J; Kwon HC; Kim YK; Kim SN
Biochem Biophys Res Commun; 2013 Mar; 432(1):73-9. PubMed ID: 23376064
[TBL] [Abstract][Full Text] [Related]
16. Oleanolic acid induces a dual agonist action on PPARγ/α and GLUT4 translocation: A pentacyclic triterpene for dyslipidemia and type 2 diabetes.
Loza-Rodríguez H; Estrada-Soto S; Alarcón-Aguilar FJ; Huang F; Aquino-Jarquín G; Fortis-Barrera Á; Giacoman-Martínez A; Almanza-Pérez JC
Eur J Pharmacol; 2020 Sep; 883():173252. PubMed ID: 32534078
[TBL] [Abstract][Full Text] [Related]
17. Anti-Diabetic Effect of a Shihunine-Rich Extract of
Li XW; Huang M; Lo K; Chen WL; He YY; Xu Y; Zheng H; Hu H; Wang J
Molecules; 2019 Jul; 24(14):. PubMed ID: 31340585
[TBL] [Abstract][Full Text] [Related]
18. Antihyperglycemic and antihyperlipidemic action of Cinnamomi Cassiae (Cinnamon bark) extract in C57BL/Ks db/db mice.
Kim SH; Choung SY
Arch Pharm Res; 2010 Feb; 33(2):325-33. PubMed ID: 20195835
[TBL] [Abstract][Full Text] [Related]
19. Artemisia scoparia enhances adipocyte development and endocrine function in vitro and enhances insulin action in vivo.
Richard AJ; Fuller S; Fedorcenco V; Beyl R; Burris TP; Mynatt R; Ribnicky DM; Stephens JM
PLoS One; 2014; 9(6):e98897. PubMed ID: 24915004
[TBL] [Abstract][Full Text] [Related]
20. Supplementation of persimmon leaf ameliorates hyperglycemia, dyslipidemia and hepatic fat accumulation in type 2 diabetic mice.
Jung UJ; Park YB; Kim SR; Choi MS
PLoS One; 2012; 7(11):e49030. PubMed ID: 23145054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
